Watchlist Price Alert

Adaptimmune Therapeutics (ADAP)

NASDAQ: ADAP · Real-Time Price · USD

0.28

-0.00 (-1.06%)

At close: Jun 09, 2025, 3:58 PM

Adaptimmune Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	91.14M	143.99M	108.03M	149.95M	56.88M	50.41M	68.38M	84.04M	158.78M
Short-Term Investments	60.47M	2.95M	96.57M	219.63M	311.33M	39.13M	136.75M	124.22M	22.69M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	4.5M	4.1M	4.25M	4.02M
Other Long-Term Assets	2.7M	3.03M	1.57M	1.72M	4.6M	7M	8.05M	8.95M	6.6M
Receivables	15.98M	46.92M	38.09M	34.01M	21.09M	19.28M	192K	206K	1.48M
Inventory	7.32M	n/a	n/a	n/a	2.09M	1.46M	1.09M	3.76M	1.19M
Other Current Assets	3.23M	3.74M	3.21M	2.83M	444K	1.81M	25.77M	17.96M	14.61M
Total Current Assets	188.17M	207.55M	255.37M	415.46M	398.15M	120.49M	231.09M	230.18M	198.75M
Property-Plant & Equipment	51.22M	71.71M	71.53M	51.37M	46.66M	51.86M	36.12M	40.68M	27.9M
Goodwill & Intangibles	3.88M	330K	442K	1M	1.73M	2.2M	1.47M	1.34M	1.27M
Total Long-Term Assets	57.79M	75.06M	73.55M	54.09M	52.99M	61.05M	45.64M	50.96M	35.76M
Total Assets	245.96M	282.62M	328.92M	469.55M	451.14M	181.54M	276.74M	281.15M	234.51M
Account Payables	8.69M	8.13M	4.75M	8.11M	6.39M	6.36M	4.08M	8.38M	11.35M
Deferred Revenue	12.3M	28.97M	23.52M	22.2M	2.83M	2.13M	n/a	38.73M	11.39M
Short-Term Debt	4.71M	n/a	2.73M	2.32M	n/a	2.49M	n/a	n/a	n/a
Other Current Liabilities	21.46M	15.68M	12.67M	12.09M	12.48M	14.01M	12.8M	6.95M	10.97M
Total Current Liabilities	64.53M	72.79M	64.5M	62.54M	39.07M	34.34M	24.44M	74.31M	40.27M
Long-Term Debt	50.24M	n/a	20.35M	23.15M	n/a	22.97M	n/a	n/a	n/a
Other Long-Term Liabilities	4.27M	1.4M	1.3M	673K	644K	-22.37M	5.41M	3.85M	3.14M
Total Long-Term Liabilities	169.59M	170.31M	182.54M	201.04M	70.84M	23.56M	5.41M	3.85M	28.1M
Total Liabilities	234.11M	243.1M	247.04M	263.58M	109.92M	57.91M	29.85M	78.16M	68.37M
Total Debt	74.21M	25.23M	23.08M	25.47M	23.71M	25.46M	136.75M	124.22M	n/a
Common Stock	2.08M	1.86M	1.4M	1.34M	1.32M	943K	939K	854K	683K
Retained Earnings	-1.09B	-1.02B	-909.3M	-743.85M	-585.76M	-455.66M	-318.5M	-231.63M	-161.49M
Comprehensive Income	-1.9M	-3.75M	-875K	-11.14M	-10.05M	-7.26M	-9.76M	-21.64M	-14.25M
Shareholders Equity	11.85M	39.51M	81.88M	205.96M	341.23M	123.64M	246.88M	202.98M	166.14M
Total Investments	60.47M	2.95M	96.57M	219.63M	311.33M	39.13M	136.75M	124.22M	22.69M